Prevalence of Asymptomatic Rupture in SILIMED Breast Implants

NCT02206282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 390

Last updated 2014-08-01

No results posted yet for this study

Summary

A prospective clinical research is to assess the prevalence of implant rupture and presence of extracapsular gel in an un-referred population of women who have been implanted with the Silimed gel-filled mammary implants with or without any local or systemic systemic symptoms.

Conditions

  • Breast Implant Rupture

Sponsors & Collaborators

  • Silimed Industria de Implantes Ltda

    lead INDUSTRY

Principal Investigators

  • Wanda Elizabeth Massiere Correa, MD · Insituto Ivo Pitanguy

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2010-11-30
Completion
2011-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02206282 on ClinicalTrials.gov